• 简

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Scandinavian Tobacco Group (CPSE:STG) Stock Faces Debt Relief Bet After Softer Margins

    Simply Wall St·08/27/2026 17:30:18
    语音播报

    Scandinavian Tobacco Group stock came into today with a quietly positive set up. The shares were up about 6.7% over the past week and roughly 5.7% over three months, yet still trading on a P/E of 9x with a discounted cash flow estimate far above the current DKK74.6 price. The headline from this earnings release is not the income statement. It is the balance sheet story as investors weigh a weak debt coverage profile against the planned DKK1.3b BREAK and Moro sale that management says should materially ease leverage.

    Is Scandinavian Tobacco Group a genuine deep value situation, or is the low P/E simply compensation for balance sheet stress and softer margins? Compare the assumptions behind that discounted cash flow gap inside our valuation analysis for Scandinavian Tobacco Group

    Q2 2026 Earnings Summary

    • Revenue Q2 2026 vs. Q2 2025: DKK 2,334.0m vs. DKK 2,361.4m (slight decline)
    • Net Income Q2 2026 vs. Q2 2025: DKK 216.9m vs. DKK 227.0m (slight decline)
    • Basic EPS Q2 2026 vs. Q2 2025: DKK 2.8 vs. DKK 2.9 (slight decline)
    • Trailing 12-Month Net Margin to Q2 2026 vs. Prior Year: 7.3% vs. 8.6% (reported margin lower year on year, partly reflecting a one off DKK 227.8m loss)

    Prefer clear visuals instead of another dense page of earnings tables and ratios? View Scandinavian Tobacco Group's full financial picture, including balance sheet trends and leverage metrics, in an easy-to-scan format in our company report for Scandinavian Tobacco Group.

    CPSE:STG Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
    CPSE:STG Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

    Scandinavian Tobacco Group: Testing The Bullish Story

    Bulls argue that Scandinavian Tobacco Group is quietly rebuilding earnings quality through Focus2030, Mac Baren integration, and growth in nicotine pouches, with margins set to recover as these pieces come together. The H1 and Q2 numbers give a mixed scorecard. Group net sales are broadly flat organically and guidance only points to net sales between a 2% decline and 2% growth, so top line acceleration is not yet visible. However, EBITDA margin before special items improved by about 1 percentage point helped by duty refunds and free cash flow before acquisitions reached DKK 422m in H1 with full year guidance of DKK 950m to 1.2b. Nicotine pouches are regaining momentum with Q2 organic growth of 8% and XQS share gains in Sweden. The planned BREAK and Moro sale of about DKK 1.3b should help move leverage toward the 2.5x target.

    Scandinavian Tobacco Group: Stress Points For The Bear Case

    Bears worry that structural declines in cigars and smoking tobacco, rising costs, and repeated special items will steadily erode margins and strain the balance sheet. Recent results partly support these concerns. Machine rolled cigars and smoking tobacco saw H1 organic net sales decline 4% and a quality issue in France triggered an inventory write down of roughly DKK 35m plus lost availability into Q3. Group guidance implies EBIT margin before special items of 13.0% to 14.5% in 2026 compared with 14.9% in 2025, so margin pressure from investments is still in play. Nicotine pouches are only about 5% of sales and H1 was down 5% after earlier inventory adjustments. Leverage around 3.0x remains above the 2.5x target. Even with the expected BREAK and Moro proceeds, the story still depends on fixing machine rolled performance and keeping special items under tighter control.

    Reveal where the apparent calm around Scandinavian Tobacco Group's DKK74.6 share price gives way to disagreement and see where the consensus models start to diverge over the next few years. Access the full multi year revenue, earnings and cash flow analyst estimates for Scandinavian Tobacco Group.

    Stay Ahead Of Your Next Move

    If the mix of low P/E, balance sheet pressure and upcoming BREAK and Moro sale has you watching Scandinavian Tobacco Group closely, register for free with Simply Wall St and add it to your Watchlist to track share price against fair value and watch how the story evolves. Once you decide to build a position, use the Portfolio Command Center to cut through noise and focus on the key updates that matter for your holdings. For a longer term view, tap into the Community to see how other investors are thinking about the same risks and potential catalysts. By surfacing hidden catalysts and risks early, Simply Wall St helps you act with confidence and stay ahead of the market.

    Seeking Alternatives Beyond Scandinavian Tobacco Group

    Fresh ideas can move quickly. Some stocks are already building breakout momentum while others stay under the radar for now. Before the best entry points get caught, consider reviewing potential opportunities soon.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.